Fib-04 Score at the End of Treatment in Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin: An Observational Study

Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2017, Vol 3, Issue 7

Abstract

Abstract: FIB-4 Score is a simple formula to predict liver fibrosis based on the standard biochemical / hematological values i.e. AST, ALT, Platelet count and age. The Score lower than 1.45 has a Negative Predictive Value (NPV) of 95% for significant fibrosis i.e. F3-F4 while, a Score of greater than 3.25 has a PPV of 80% for advance fibrosis i.e. F3-F4. So an improvement of FIB-4 Score is a possible indicator of change in liver fibrosis. The objective is to observe the disparity in paired FIB-04 Score in hepatitis C patients treated with pegylated interferon and ribavirin at the beginning of the treatment and at the end of treatment evaluation (ETR).An observational study was carried out in patients with mono-infected, compensated CHC patients ,treated with Pegylated Interferon & Ribavirin for 24weeks to 48 weeks (according to genotype)in a tertiary care hospital (i.e. Baqai Medical University Hospital Nazimabad) from Jan 2010 to March 2015 in a paired manner i.e. before (at beginning) and at the End of treatment evaluation (ETR). Responses were analyzed by using ‘Wilcoxon signed rank test. SPSS 23.00 version was used to analyze data.Fifty eight patients diagnosed with hepatitis C took part in the study out of which 24 were males (41.4%) with mean age 38.8 (22y-60y) and 34 were females (58.6%) with mean age 43.6 (31y-60y). Out of 58 participants, 8 patients were type 1 genotype, 48 patients were type 3 genotype and 1 was type 4. Genotype of 1 participant was not recorded. According to result evaluated, there is a statically significant decrease in FIB04 score from beginning of treatment (M=2.52, SD=1.35) to ETR (M=1.74, SD=1.37) justifying that there is a definite positive change in FIB-04 score (i.e. improvement in fibrosis). Distinct positive change in FIB-4 Score was observed in Chronic Hepatitis C patients treated with pegylated interferon/ribavirin at the end of treatment. Keywords: FIB-04 Score, hepatitis C, ribavirin, pegylated interferon

Authors and Affiliations

Muhammad Imran, Karim Kammeruddin, Nida Sajid, Amjad Iqbal

Keywords

Related Articles

ChondroidSyringoma of theEyebrow about A Case

Abstract:Chondroidsyringoma is a rare benign skin tumor that is mainly located on the face and neck. It is characterized by a high risk of recurrence, hence the interest of complete excision and prolonged surveillance. A...

The Impact of Leadership Styles on Staff Nurses’ Turnover Intentions

Abstract:Head nurses are the important part of administration. The responsibilities of head nurses are to manage the nurses properly and provide the best quality of care to the patients. The provision of the supportive l...

A Case of Minocycline Induced Buccal Mucosa Hyper pigmentation

Abstract: We present a patient exposed to minocycline for 3 years for treatment of resacea, presenting with disfiguring buccal mucosa hyper pigmentation. Discontinuation of the minocycline resulted in dramatic improvemen...

Nurses’ Stressors Related to Business Environment and Their Coping Strategies

Abstract: Stress is a sad situation that leads to the desperation of the individual, a situation that occurs when the physical and mental limits of the organism are forced and threatened, affecting the lives of the indiv...

Assessment of Type and Severity of Road Traffic Accident Injuries among Omani Young Adults

Abstract: It was carried out to evaluate and assess types of injuries in road traffic accident and their severity reported to one of the tertiary care hospital through cross sectional systemic prospective and retrospecti...

Download PDF file
  • EP ID EP391728
  • DOI -
  • Views 72
  • Downloads 0

How To Cite

Muhammad Imran, Karim Kammeruddin, Nida Sajid, Amjad Iqbal (2017). Fib-04 Score at the End of Treatment in Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin: An Observational Study. Saudi Journal of Medical and Pharmaceutical Sciences, 3(7), 748-751. https://europub.co.uk./articles/-A-391728